Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 242

1.

Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial.

Kranzler HR, Wesson DR, Billot L; DrugAbuse Sciences Naltrexone Depot Study Group.

Alcohol Clin Exp Res. 2004 Jul;28(7):1051-9.

PMID:
15252291
[PubMed - indexed for MEDLINE]
2.

Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.

Galloway GP, Koch M, Cello R, Smith DE.

BMC Psychiatry. 2005 Apr 1;5:18.

PMID:
15804355
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Early treatment response in alcohol dependence with extended-release naltrexone.

Ciraulo DA, Dong Q, Silverman BL, Gastfriend DR, Pettinati HM.

J Clin Psychiatry. 2008 Feb;69(2):190-5.

PMID:
18348601
[PubMed - indexed for MEDLINE]
4.

Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.

O'Malley SS, Garbutt JC, Gastfriend DR, Dong Q, Kranzler HR.

J Clin Psychopharmacol. 2007 Oct;27(5):507-12.

PMID:
17873686
[PubMed - indexed for MEDLINE]
5.

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.

Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B.

Alcohol Alcohol. 2000 Nov-Dec;35(6):587-93.

PMID:
11093966
[PubMed - indexed for MEDLINE]
Free Article
6.

A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence.

Johnson BA, Ait-Daoud N, Aubin HJ, Van Den Brink W, Guzzetta R, Loewy J, Silverman B, Ehrich E.

Alcohol Clin Exp Res. 2004 Sep;28(9):1356-61.

PMID:
15365306
[PubMed - indexed for MEDLINE]
7.

Effectiveness of naltrexone in a community treatment program.

Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, Anton RF.

Alcohol Clin Exp Res. 2004 Nov;28(11):1710-7.

PMID:
15547458
[PubMed - indexed for MEDLINE]
8.

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.

Guardia J, Caso C, Arias F, Gual A, Sanahuja J, Ramírez M, Mengual I, Gonzalvo B, Segura L, Trujols J, Casas M.

Alcohol Clin Exp Res. 2002 Sep;26(9):1381-7.

PMID:
12351933
[PubMed - indexed for MEDLINE]
9.

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.

Balldin J, Berglund M, Borg S, Månsson M, Bendtsen P, Franck J, Gustafsson L, Halldin J, Nilsson LH, Stolt G, Willander A.

Alcohol Clin Exp Res. 2003 Jul;27(7):1142-9.

PMID:
12878920
[PubMed - indexed for MEDLINE]
10.

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.

Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA.

J Clin Psychopharmacol. 2006 Dec;26(6):610-25. Review.

PMID:
17110818
[PubMed - indexed for MEDLINE]
11.

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.

Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.

Arch Gen Psychiatry. 2005 Jan;62(1):37-45.

PMID:
15630071
[PubMed - indexed for MEDLINE]
12.

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study.

Gastpar M, Bonnet U, Böning J, Mann K, Schmidt LG, Soyka M, Wetterling T, Kielstein V, Labriola D, Croop R.

J Clin Psychopharmacol. 2002 Dec;22(6):592-8.

PMID:
12454559
[PubMed - indexed for MEDLINE]
13.

Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.

O'Malley SS, Sinha R, Grilo CM, Capone C, Farren CK, McKee SA, Rounsaville BJ, Wu R.

Alcohol Clin Exp Res. 2007 Apr;31(4):625-34.

PMID:
17374042
[PubMed - indexed for MEDLINE]
14.

Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.

Pettinati HM, Silverman BL, Battisti JJ, Forman R, Schweizer E, Gastfriend DR.

Alcohol Clin Exp Res. 2011 Oct;35(10):1804-11. doi: 10.1111/j.1530-0277.2011.01524.x. Epub 2011 May 16.

PMID:
21575016
[PubMed - indexed for MEDLINE]
15.

Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.

Karhuvaara S, Simojoki K, Virta A, Rosberg M, Löyttyniemi E, Nurminen T, Kallio A, Mäkelä R.

Alcohol Clin Exp Res. 2007 Jul;31(7):1179-87. Epub 2007 Apr 19.

PMID:
17451401
[PubMed - indexed for MEDLINE]
16.

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.

Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, Loewy JW, Ehrich EW; Vivitrex Study Group.

JAMA. 2005 Apr 6;293(13):1617-25. Erratum in: JAMA. 2005 Apr 27;293(16):1978. JAMA. 2005 Jun 15:293(23):2864.

PMID:
15811981
[PubMed - indexed for MEDLINE]
17.

Naltrexone's suppressant effects on drinking are limited to the first 3 months of treatment.

Davidson D, Wirtz PW, Gulliver SB, Longabaugh R.

Psychopharmacology (Berl). 2007 Sep;194(1):1-10. Epub 2007 May 19.

PMID:
17514344
[PubMed - indexed for MEDLINE]
18.

Naltrexone for alcohol dependence: a randomized controlled trial.

Morris PL, Hopwood M, Whelan G, Gardiner J, Drummond E.

Addiction. 2001 Nov;96(11):1565-73.

PMID:
11784454
[PubMed - indexed for MEDLINE]
19.

Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.

O'Malley SS, Rounsaville BJ, Farren C, Namkoong K, Wu R, Robinson J, O'Connor PG.

Arch Intern Med. 2003 Jul 28;163(14):1695-704.

PMID:
12885685
[PubMed - indexed for MEDLINE]
20.

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial.

Heinälä P, Alho H, Kiianmaa K, Lönnqvist J, Kuoppasalmi K, Sinclair JD.

J Clin Psychopharmacol. 2001 Jun;21(3):287-92.

PMID:
11386491
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk